The Daily Telegraph

Unilever’s £50bn offer for GlaxoSmithKline’s consumer health unit was rejected, so it will either have to “raise its bid or walk away”. There is a danger of overpaying, bidding wars and “battles for regulatory clearance”. But the deal seems unlikely to go ahead, so hold on (3,517p). Doric Nimrod Air Three suffered in the pandemic as investors shunned its aircraftleasing business model. But it has declared an unchanged quarterly dividend of 2.0625p and has an “extraordinary” yield of 21.7%. Hold (38p).

Investors’ Chronicle

“Parking excess stuff in safe storage is now a permanent feature of modern life” due to the decreasing size of modern houses. That’s great for Safestore. Hold (1,320p).

Best of the Best, which runs online competitions, saw a surge in activity throughout the pandemic. The shares have sold off due to weaker guidance, but revenues are still at twice the level they were reaching before it went fully digital shortly before the pandemic. Hold (450p).

Shares

Shares in video-game developer Frontier Developments fell following a downgrade to forecasts for 2022 and 2023, but the issue seems to be “management’s overly ambitious guidance rather than fundamental development of the business”. The potential is still there. Buy (1,330p).

Motley Fool

Vistry Group’s low share price “belies the possibility of strong and sustained profits growth”. The housebuilder’s cheapness reflects concerns that demand for new-build properties will fall, but low mortgage rates and government support should prevent that. Buy (1,080p).